GSK, other drugmakers bet on post-Brexit UK science

LONDON (Reuters) – Britain won a vote of confidence from its economically important life sciences sector on Wednesday as several major drug companies committed to invest in the country under the government’s industrial strategy plans after Brexit.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply